News

Oncolytics Biotech (R) Announces a Publication Highlighting Synergistic Effect of Pelareorep with a Proteasome Inhibitor in Preclinical Models of Multiple Myeloma

- Combination Synergistic Even in Cells That Have Developed Resistance to Bortezomib - Article Published in the March 12 Edition...

Aytu BioScience Provides Study Update for Spermatogenesis Study of Natesto (R), the Only FDA-Approved, Nasally-Administered Testosterone Treatment

Interim Results Demonstrated Preservation of Sperm Parameters After Six Months of Treatment with Nasally-Administered Natesto Testosterone Gel Natesto Spermatogenesis Study...

Addressing Health Access Challenges for Transgender and Non-binary Community, Backpack Health Establishes Dedicated Group on its Health Data Management Platform

DOVER, Mass., March 26, 2019 /PRNewswire/ -- Backpack Health, LLC today announced the launch of a dedicated group for transgender and...

Clinical Study Finds Combining Patient Risk Stratification With EarlySense Continuous Monitoring can Reduce Clinician Work Load and Improve Patient Sleep and Satisfaction

WOBURN, Massachusetts, March 26, 2019 /PRNewswire/ -- EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, announced...

error: Content is protected !!